• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Impact of a program designed to improve continuous renal replacement therapy stability].

作者信息

Page M, Rimmelé T, Prothet J, Christin F, Crozon J, Ber C-E

机构信息

Service d'anesthésie-réanimation, pavillon P réanimation, hôpital Édouard-Herriot, 5, place d'Arsonval, 69437 Lyon cedex 03, France.

Service d'anesthésie-réanimation, pavillon P réanimation, hôpital Édouard-Herriot, 5, place d'Arsonval, 69437 Lyon cedex 03, France.

出版信息

Ann Fr Anesth Reanim. 2014 Dec;33(12):626-30. doi: 10.1016/j.annfar.2014.10.008. Epub 2014 Nov 15.

DOI:10.1016/j.annfar.2014.10.008
PMID:25458458
Abstract

OBJECTIVES

During continuous renal replacement therapy (CRRT), circuit clotting increases nursing workload, cost of the therapy and blood loss. The aim of this study was to assess the impact of a program designed to improve CRRT stability on unexpected circuit clotting.

STUDY DESIGN

Retrospective and observational study.

PATIENTS AND METHODS

In January 2011, several changes have been adopted regarding CRRT management. Regional citrate anticoagulation, continuous hemodialysis using super high-flux membranes and a specific training for intensive care unit nurses were implemented. CRRT sessions before (year 2009 and 2010, "Before group") and after (year 2011 and 2012, "After group") were analyzed. The primary endpoint was the incidence of unexpected CRRT session end.

RESULTS

During the study period, 401 sessions performed in 152 patients were analyzed. Sixty-three unexpected session's end (40%) occurred before and 43 (17%) after the implementation of the program (P<0.0001). Median filter life time was 33 (13-48) hours before and 55 (27-67) hours after (P<0.0001).

CONCLUSION

Our program designed to improve CRRT stability reduced filter losses by reducing unexpected circuit clotting.

摘要

相似文献

1
[Impact of a program designed to improve continuous renal replacement therapy stability].
Ann Fr Anesth Reanim. 2014 Dec;33(12):626-30. doi: 10.1016/j.annfar.2014.10.008. Epub 2014 Nov 15.
2
Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.在连续性肾脏替代治疗中,局部枸橼酸盐抗凝是否优于全身肝素抗凝?一项在成人区域重症监护系统中的前瞻性观察研究。
J Crit Care. 2005 Jun;20(2):155-61. doi: 10.1016/j.jcrc.2005.01.001.
3
Citrate clearance in children receiving continuous venovenous renal replacement therapy.接受持续静静脉肾脏替代治疗的儿童的枸橼酸盐清除率
Pediatr Nephrol. 2002 Oct;17(10):819-24. doi: 10.1007/s00467-002-0963-6. Epub 2002 Sep 7.
4
Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.局部枸橼酸抗凝用于高出血风险外科患者的大容量连续性静脉-静脉血液透析
Ther Apher Dial. 2013 Apr;17(2):202-12. doi: 10.1111/j.1744-9987.2012.01101.x. Epub 2012 Aug 29.
5
Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.用于PrismaFlex持续肾脏替代治疗的局部枸橼酸盐抗凝法。
Ann Pharmacother. 2009 Sep;43(9):1419-25. doi: 10.1345/aph.1M182. Epub 2009 Aug 18.
6
Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different?肝脏疾病患者的连续肾脏替代治疗(CRRT): 回路寿命是否不同?
J Hepatol. 2009 Sep;51(3):504-9. doi: 10.1016/j.jhep.2009.05.028. Epub 2009 Jun 24.
7
Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.连续性肾脏替代治疗:对出血高风险的危重症患者进行抗凝治疗。
J Nephrol. 2003 Jul-Aug;16(4):566-71.
8
Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: the Filter Life in Renal Replacement Therapy pilot trial.软件算法驱动的局部枸橼酸抗凝与肝素在连续肾脏替代治疗中的随机对照试验:滤过寿命在肾脏替代治疗中的初步试验。
Crit Care Resusc. 2014 Jun;16(2):131-7.
9
Clinical review: Patency of the circuit in continuous renal replacement therapy.临床综述:连续性肾脏替代治疗中血管通路的通畅性
Crit Care. 2007;11(4):218. doi: 10.1186/cc5937.
10
Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy.肝移植术后需要肾脏替代治疗的患者应用局部枸橼酸抗凝的疗效和安全性。
Nephrol Dial Transplant. 2012 Apr;27(4):1651-7. doi: 10.1093/ndt/gfr510. Epub 2011 Nov 1.

引用本文的文献

1
Feasibility and efficacy of modified fixed citrate concentration protocol using only commercial preparations in critically ill patients: a prospective cohort study with a historical control group.仅使用商业制剂的改良固定柠檬酸盐浓度方案在危重症患者中的可行性和疗效:前瞻性队列研究及历史对照研究。
BMC Anesthesiol. 2021 Mar 30;21(1):96. doi: 10.1186/s12871-021-01319-4.
2
Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit.重症监护病房连续性肾脏替代治疗质量保证体系的建立、实施和效果评价。
Sci Rep. 2020 Nov 26;10(1):20616. doi: 10.1038/s41598-020-76785-w.
3
Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis.
连续肾脏替代治疗(CRRT)中与滤器寿命相关的非抗凝因素:一项系统评价和荟萃分析。
BMC Nephrol. 2017 Feb 20;18(1):69. doi: 10.1186/s12882-017-0445-5.